Shares of Humana (NYSE:HUM) surged 12% in after-hours trading Monday following the Centers for Medicare and Medicaid Services’ announcement that private insurers will receive a 2.48% rate increase for 2027.
The rate decision also coincided with notable gains across other major health insurers in extended hours: UnitedHealth Group (NYSE:UNH) rose 11%, CVS Health (NYSE:CVS) climbed 9%, and Elevance Health (NYSE:ELV) increased 5%.
Hospital-focused and managed-care names also moved higher after the announcement, with Molina Healthcare (NYSE:MOH) up 7% and Centene (NYSE:CNC) rising 4% in after-hours trading.
The finalized 2.48% adjustment represents a clear improvement compared with the initial rates the agency set out in January, according to the statement accompanying the decision. The Centers for Medicare and Medicaid Services' rate-setting influences the payments private insurers receive for offering Medicare Advantage plans to beneficiaries - a direct revenue lever for companies active in that market.
Market reactions in the extended session reflected the sensitivity of Medicare Advantage-focused business models to the federal rate-setting process. Insurers that rely on these payments for a material portion of their Medicare-related revenue saw the strongest moves.
Questions about investor appetite for specific insurers and the broader implications for provider contracting and plan design remain outside the scope of the agency’s announcement; the published rate and the market's immediate response are the only confirmed elements provided.
For investors tracking individual stocks, AI-driven screening tools and other stock idea services referenced by market participants often evaluate companies such as Elevance Health alongside thousands of other companies using a wide range of financial metrics. Those tools aim to compare fundamentals, momentum, and valuation, though their assessments and model outputs are separate from the regulatory rate decision.
Contextual note - The decision by the Centers for Medicare and Medicaid Services directly affects payments to private insurers that operate Medicare Advantage plans; the agency's announced 2.48% increase is the primary factual driver cited for the after-hours price moves.